Activity of Delafloxacin and Comparator Fluoroquinolones against Multidrug-Resistant <i>Pseudomonas aeruginosa</i> in an In Vitro Cystic Fibrosis Sputum Model

Delafloxacin (DLX) is a recently approved fluoroquinolone with broad activity against common cystic fibrosis (CF) pathogens, including multidrug-resistant <i>Pseudomonas aeruginosa</i> (MDR-Psa). Delafloxacin has been previously shown to have excellent lung and biofilm penetration and enhanced activ...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Vaughn D. Craddock, Evan L. Steere, Hannah Harman, Nicholas S. Britt
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2023-06-01
Serie:	Antibiotics
Soggetti:	delafloxacin <i>Pseudomonas aeruginosa</i> multidrug-resistance carbapenem-resistance carbapenem-resistant <i>Pseudomonas aeruginosa</i> cystic fibrosis
Accesso online:	https://www.mdpi.com/2079-6382/12/6/1078
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!